Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers

By Munzel U.   Marschall K.   Fyrnys B.   Wedel M.  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 827-834

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease

By Zhong Nanshan   Zheng Jinping   Wen Fuqiang   Yang Lan   Chen Ping   Xiu Qingyu   Yao Wanzhen   Sun Tieying   Zhao Ziwen   Shen Huahao   Shi Yi   Lin Jiangtao   Li Qiang  

Current Medical Research and Opinion, Vol. 28, Iss. 2, 2012-02 ,pp. : 257-265

Informa Healthcare

Access to resources Recommend Favorite

Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers

By Persson Gunnar   Ankerst Jaro   Gillen Michael   Bengtsson Thomas   Thorsson Lars  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1511-1517

Informa Healthcare

Access to resources Recommend Favorite

Dry Powder Inhalers and the Risk of Error

By  

Respiration, Vol. 75, Iss. 1, 2008-01 ,pp. : 14-15

Karger

Access to resources Recommend Favorite

Clinical Equivalence Trial on Budesonide Delivered either by the Novolizer^® Multidose Dry Powder Inhaler or the Turbuhaler^® in Asthmatic Patients

By  

Respiration, Vol. 69, Iss. 6, 2002-12 ,pp. : 502-508

Karger

Access to resources Recommend Favorite